High Purity Pharmaceutical Grade 25316-40-9 Doxorubicin Hydrochloride ad Cancri Treatment
Productumnomen | Doxorubicin Hydrochloride |
Synonyma | (8S-cis) -10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy. -8-(hydroxyacetyl) -1-methoxynaphthacene-5,12-dione hydrochloride |
CAS Non. | 25316-40-9 |
Aspectus | Orange-rubrum vel rubrum crystallinum pulveris |
Formulae hypotheticae | C27H29NO11.HCl |
M. Pondus | 579.99 |
Consuetudinem | Pharmaceutical gradus seu investigationis propositum |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
Product Name: Doxorubicin Hydrochloride CAS No.:25316-40-9 | ||
ITEMS | SIGNA | Effectus |
Aspectus | Orange-ruber vel rubeus crystallinus pulveris;Nullum indicium contagione visibilis ab re aliena | Obsequitur |
Solubilitas | Methanolum in aqua solutum;leviter solutum in ethanol.in acetone fere insolubilis. | Obsequitur |
Lepidium sativum | A: IR spectrum respondet IR spectro relationis vexillum | Obsequitur |
B: Retentionis tempus doxorubicinorum in chromatogrammo praeparationis Invasionis respondet in chromatogrammo Praeparatio sacra, prout habetur in Assy. | Obsequitur | |
pH | 4.0 ad 5.5 | 4.9 |
Aquae | Non plus quam 4.0% | 2.1% |
Substantiae cognatae | Impuritas A (Doxorubicinone) ≤0.5% | 0.23% |
Alia alia ignota immunditia ≤0.2% | 0.17% | |
Totalis ignotae immunditias ≤0.5% | 0.37% | |
Totalis immunditias ≤2.0% | 0.6% | |
RELICTUM Solvents | Acetone ≤ 0.5% Acetone +Ethanol ≤ 2.5% methanolum ≤ 0,3% Dichloromethane ≤ 0.06% | 0.34% 1.6% 0.07% Non Results |
Assay | 98.0% ~ 102.0% | 99.2% |
Conclusio: Eventus ad normam USP34 conformes sunt. |